NextGen Healthcare
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of NextGen Healthcare generated cash of $43,660,000, which is less than the previous year. Cash used in financing activities reached the amount of $212,623,000 last year. Net change in cash is therefore $39,241,000.
Cash Flow
| 2014 | 104.14M | -63.75M | -43.24M |
|---|---|---|---|
| 2015 | 82.75M | -24.52M | -42.38M |
| 2016 | 40.79M | -190.37M | 57.76M |
| 2017 | 110.59M | -11.40M | -88.69M |
| 2018 | 76.58M | -91.53M | 6.11M |
| 2019 | 50.47M | -25.52M | -21.64M |
| 2020 | 85.60M | -96.07M | 116.26M |
| 2021 | 98.51M | -28.54M | -131.71M |
| 2022 | 53.54M | -28.08M | -37.29M |
| 2023 | 43.66M | -216.89M | 212.62M |
NXGN Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 66.74M | 78.57M | 140.31M | 34.52M | 31.21M | 37.67M | 27.17M | 118.99M | 103.14M | 105.99M |
Operating activities | ||||||||||
Net income | -2.65M | 1.61M | 9.51M | 7.49M | 24.49M | 2.42M | 18.24M | 5.65M | 27.33M | 15.68M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 36.69M | 42.31M | 49.21M | 47.79M | 43.13M | 40.39M | 40.43M | 29.73M | 29.26M | 28.73M |
Stock-based compensation expense | 33.45M | 26.55M | 22.71M | 19.69M | 16.10M | 12.29M | 7.59M | 3.29M | 3.47M | 2.49M |
| Deferred income tax benefit | 33.45M | 26.55M | 22.71M | 19.69M | 16.10M | 12.29M | 7.59M | 3.29M | 3.47M | 2.49M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -12.37M | -431K | -369K | 4.93M | -6.17M | -5.40M | 5.53M | 9.92M | 4.74M | 40.54M |
Inventories | 0 | 0 | -22.65M | -8.22M | 70K | -73K | -21K | 17K | 187K | -81K |
Accounts payable | 333K | -2.32M | 615K | 3.33M | 1.07M | -1.23M | -6.59M | -271K | 1.28M | -4.17M |
Cash generated by operating activities | 43.66M | 53.54M | 98.51M | 85.60M | 50.47M | 76.58M | 110.59M | 40.79M | 82.75M | 104.14M |
Investing activities | ||||||||||
Purchases Of Investments | -140.08M | 0 | 0 | 0 | 0 | 0 | 0 | -6.63M | -12.12M | 0 |
Investments In Property Plant And Equipment | -37.26M | -28.08M | -28.33M | -26.88M | -25.52M | -28.66M | -20.41M | -28.68M | -21.13M | -28.71M |
Acquisitions Net | -51.30M | 0 | -206K | -71.69M | 0 | -62.86M | -282K | -163.84M | -2.34M | -35.03M |
Cash generated by investing activities | -216.89M | -28.08M | -28.54M | -96.07M | -25.52M | -91.53M | -11.40M | -190.37M | -24.52M | -63.75M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -42.85M | -42.77M | -42.20M |
Repurchases of common stock | -49.87M | -35.87M | -4.77M | -4.14M | -3.18M | -848K | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -179M | -19M | 0 | -28M | 0 | -68.50M | 0 | 0 |
Cash used in financing activities | 212.62M | -37.29M | -131.71M | 116.26M | -21.64M | 6.11M | -88.69M | 57.76M | -42.38M | -43.24M |
Net Change In Cash | 39.24M | -11.82M | -61.74M | 105.79M | 3.30M | -8.82M | 10.49M | -91.81M | 15.84M | -2.85M |
Cash at end of period | 105.98M | 66.74M | 78.57M | 140.31M | 34.52M | 28.84M | 37.67M | 27.17M | 118.99M | 103.14M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |